Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
BACKGROUND: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on the e...
Enregistré dans:
| Publié dans: | CMAJ |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Canadian Medical Association
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12975222/ |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|